Pricing on the wrong model
Per-seat when usage or hybrid fits. Per-seat fell 64% to 57% in a year - the 2025 reset most of your peers are already making.
SaaS revenue diagnostic
Find the revenue your SaaS is quietly losing.
An independent, written diagnosis of your pricing, retention and activation. Every leak located, priced and ranked, then reviewed and signed by the founder.
7 questions · 3 minutes · no email needed to see your grade
Reviewed and signed by Waleed Alvi, PMP® · RMP®
No calls, written report
UK company 17258465
Revenue Integrity BriefIllustrative sample
NRR sitting at 94%. The pricing model is the wrong fork.
- Pricing-model verdictMove to hybrid
- NRR vs $750K–$30M median (~98–100%)−4 pts
- Activation / time-to-value9.2 days
- AI-defensibility moat3.4 / 5
- Annual leak (modeled)$1.2M / yr
Where revenue leaks
The leaks we find most often in SaaS companies.
Underpriced vs the value you deliver
SaaS is underpriced 30-50% against the value it delivers; ~40% haven't touched pricing in 18 months. The gap is usually $200K-$800K a year.
NRR quietly under 100%
Below 100% net revenue retention means you're shrinking your existing base before a single new sale - and your next round is priced on NRR.
How it works
Three steps. No meetings.
Every tier follows the same path. Only the depth of the diagnosis changes with the price.
Pick your diagnostic
Choose the tier that fits your ARR, or take the free grade first and let it point you to one.
2 minutesAnswer the intake
18 questions on pricing, retention and pipeline. Anything you don't have is flagged in the report, never guessed.
About 15 minutesGet your written report
Every leak located, priced and ranked, with the fixes in order, reviewed and signed by the founder.
Within 18–24 hoursTry it on your numbers
Estimate your leak in 30 seconds.
Four inputs, one directional estimate from published benchmarks. It is a preview, not the diagnostic.
50/100
Estimated annual recoverable
$0
Directional only. The diagnostic replaces every estimate with a figure from your own numbers.
What the diagnostic reads first
Five frameworks built for the questions your board actually asks.
F1
Pricing-model fit
Keep per-seat, move to usage, or hybrid - and what does that do to revenue + the next raise?
F2
Monetization / WTP gap
How underpriced are you vs the value you deliver, and which packaging move closes the gap?
F3
NRR & expansion
Where exactly is NRR leaking - downsell, churn, or flat expansion - and what's the dollar repair?
F4
AI-defensibility moat
Could one person + AI rebuild this in a weekend? The board / acquirer DD question.
F5
Gross-margin integrity
Are your gross margins SaaS-grade (75-80%+) or quietly eroding under inference / hosting costs?
These five are read first. Each tier below states exactly how far the diagnosis goes beyond them.
Pricing
One-time price. No retainer, no calls.
Pick the tier that matches your ARR. Every diagnostic is reviewed and signed by the founder and delivered in writing.
Often from pricing gaps and activation drop-off
You leave with
- Top 3 leak areas named and located
- Dollar estimate on your largest single gap
- One immediate action ranked by impact
- Where to look first
Often from early churn signals and pricing friction
You leave with
- 8 revenue areas diagnosed
- Each gap dollar-quantified and ranked
- Pricing assessment — raise, repackage, or hold
- Priority fix sequence for the next 30 days
Often from expansion gaps and seat underutilization
You leave with
- All 18 vertical frameworks scored, every gap named
- Dollar-quantified findings benchmarked to peers
- Pricing-fork verdict with recommendation
- AI-defensibility read + 30-day action queue
Often from churn compounding and monetization drag
You leave with
- Full 18-framework diagnostic + competitive layer
- Peer benchmark comparisons by ARR band
- Board-ready executive brief, pre-formatted
- 90-day revenue recovery roadmap
Often from NRR drag and pricing model misalignment
You leave with
- Complete revenue architecture map, all 18-frameworks
- NRR and retention modelling included
- Investor-grade findings, Series C narrative ready
- Cross-functional implementation priorities
Card, Apple Pay or Google Pay. Bank transfer (Wise) on Founder, Growth and Scale.Useful, or we rework it free. All sales final.Not sure which? Take the free grade first
Sample report
What you actually receive.
- Cited benchmarks
- Dollar-quantified findings
- Pricing-fork verdict
- AI-moat assessment
Format
A structured Internal Revenue Brief — your findings named, located, and dollar-quantified. Includes a prioritised action list, pricing-fork verdict, AI-defensibility read, and 30-day priority queue. Delivered by email. No PDF downloads, no logins required.
Who runs your diagnostic
Reviewed and signed by the founder.
PMP®- and RMP®-certified senior planning engineer (BEng Hons). Every diagnostic is personally run, reviewed and signed by me — no outsourced analysts, no call-booking funnel. The methodology is public: judge the teardowns before you spend a dollar.
Judge the method before you buy. Public teardowns:
Waleed AlviFounder, Intake Review · PMP® · RMP® · BEng (Hons)
- CompanyIntake Review Ltd · UK Companies House No. 17258465
- Registered office71-75 Shelton Street, London WC2H 9JQ
- How we workWritten reports only. A clarifying question comes by email, never a meeting.
- Contacthello@intakereview4500.com
- ProfileLinkedIn
Useful, or we rework it free.
If a finding doesn't hold up, a number needs sharpening or an input is missing, we rework the diagnostic at no charge until you can act on it. All sales are final; the rework is the guarantee.
Questions
What founders ask before buying.
Really no calls?
Right - insight in hours, not weeks of discovery calls. You fill the intake, we deliver a written report; your time stays yours. The only exception: if a finding needs a clarifying question, we ask it by email - never a meeting.
What if my data is incomplete?
We infer from your stage, ARR, headcount, and pricing model using cited benchmarks. Every assumption is flagged. A complete, useful diagnostic still ships - and we tell you exactly which 3 numbers to capture to upgrade it.
Is the diagnostic worth it?
Even a 1% pricing or retention gain at your ARR returns the fee many times over - and the typical pricing upside runs 11-15%: $550K-$750K a year at $5M ARR, far more at scale. We sit 4x below the cheapest boutique alternative. And we don't stop at delivered: if it isn't useful, we rework it free until it is.
What format is the report?
A structured Internal Revenue Brief — your findings named, located, and dollar-quantified. Includes a prioritised action list, pricing-fork verdict, AI-defensibility read, and 30-day priority queue. Delivered by email. No PDF downloads, no logins required.
How do you handle confidentiality?
A standard mutual NDA on request, sent before intake. We work on an anonymized basis only - no name, logo, or identifying figures leave our system, and your data is never shared or resold.
Who is this for?
B2B SaaS founders, CEOs, CROs, and Heads of Growth at $750K-$50M ARR, 8-200 staff, from post-seed through Series B. If you're earlier than that, run the free scorecard first to see where you stand.
Know exactly where your revenue leaks.
Start with the free grade. When you're ready, the diagnostic puts a dollar figure and a fix on every leak.